Indegene (INDGN) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
31 Jul, 2026Executive summary
Q1 FY 2027 revenue reached INR 10,631 million ($112.5 million), up 39.7% year-on-year and 6% quarter-on-quarter, marking the strongest first-quarter sequential growth in four years.
Active client base expanded to 105, up 50% year-over-year, with 14 new clients added sequentially.
Revenue per employee rose to $77,100, a 14.2% increase year-over-year, reflecting improved productivity.
EBITDA margin stood at 16.9%, and PAT margin at 10.9%, both improving sequentially.
The company continues to invest in AI-driven solutions and technology, expanding offerings and deepening client relationships.
Financial highlights
EBITDA for Q1 FY 2027 was INR 1,795 million at a margin of 16.9%, up 50 bps quarter-on-quarter and 8.9% sequentially.
PAT was INR 1,162 million, stable year-over-year but up 45.9% sequentially, with PAT margin at 10.9%.
Cash and cash equivalents plus investments stood at INR 14,602 million at quarter end.
Operating expenses for the quarter were INR 9,394 million, up from INR 6,308 million year-over-year.
DSO (net of unearned and unbilled revenue) was 67 days, up four days quarter-on-quarter and improved by four days year-over-year.
Outlook and guidance
Organic growth in FY 2027 expected to surpass FY 2026, with acceleration anticipated in H2.
Margin normalization to historical 19%-20% EBITDA range projected by Q4 FY 2027 as large outcome-based deals begin to be recognized.
Management expects further operating leverage and profitability improvements in the second half as recent investments mature.
Board proposed a final dividend of INR 2.25 per equity share for FY26, subject to shareholder approval.
Focus remains on deepening existing client relationships and converting pipeline opportunities.
Latest events from Indegene
- AI-powered, domain-led platforms are set to dominate the rapidly centralizing pharma services market.INDGN
Investor presentation - Revenue up 23.6% YoY, EBITDA margin steady, strong cash flow, and dividend raised 12.5%.INDGN
Q4 25/26 - Q3 revenue up 30.8% YoY, surpassing $100M, with strong AI-driven deals and robust cash flow.INDGN
Q3 25/26 - Q2 FY26 revenue and profit rose double digits, supported by acquisitions and digital investments.INDGN
Q2 25/26 - Q1 FY25 saw double-digit growth, margin expansion, and a debt-free, cash-rich balance sheet.INDGN
Q1 24/25 - Q2 FY25 revenue up 8.8% YoY, higher margins, strong cash, and positive outlook post-IPO.INDGN
Q2 24/25 - Q3 FY25 saw strong revenue, margin, and profit growth, plus a successful IPO and robust cash reserves.INDGN
Q3 24/25 - FY25 saw robust growth, record margins, IPO completion, and a 100% dividend declared.INDGN
Q4 24/25 - Q1 FY26 delivered strong revenue and profit growth, stable margins, and progress in strategic initiatives.INDGN
Q1 25/26